Smith & Nephew SNATS, Inc
Smith & Nephew plc is a UK-founded medical technology company that develops and sells orthopedic, sports medicine, ENT, and advanced wound care products. Its business serves hospitals, surgeons, clinicians, and other healthcare providers through a global network spanning about 100 countries.
Business
Share of revenueJoint reconstruction, trauma, and related orthopedic implants and systems.
Arthroscopic, sports injury, and ear, nose, and throat surgical devices.
Dressings, wound closure, and therapies for complex wound care.
Customers
Smith & Nephew sells primarily to healthcare providers that use its products in surgery, wound treatment, and hospital care. Demand comes from clinicians and purchasing organizations that specify products for orthopedic procedures, sports injury repair, ENT procedures, and chronic or acute wound management. The business is shaped by procedure volumes, hospital purchasing cycles, and clinical preference for its branded technologies.
Buy implants, surgical devices, and wound products for inpatient and outpatient procedures.
Use joint reconstruction, trauma, and related systems in orthopedic procedures.
Buy arthroscopy, soft-tissue repair, and ENT instruments for procedural use.
Purchase dressings and therapies for chronic, surgical, and hard-to-heal wounds.
Tender and contract buyers that influence pricing, product access, and volume.
Strategy
The company’s strategy centers on improving its portfolio through product innovation in Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. Its global scale and clinical breadth are important because they support surgeon adoption, hospital relationships, and cross-selling across procedure types.
Clinical performance and new technology adoption are central to share gains in medtech.
A broad geographic footprint helps diversify demand and access large procedure markets.
Multiple adjacent categories reduce dependence on any single procedure area.
Geography
Smith & Nephew operates globally and reports business across around 100 countries, with a major international footprint centered in Europe, North America, and other overseas markets. Its UK roots and global distribution base mean revenue is tied to healthcare spending patterns, tender systems, and procedure volumes across multiple regions.
Risks
Smith & Nephew faces typical medtech risks from regulation, product quality, and reimbursement pressure, because its products are used in invasive procedures and sold into regulated healthcare systems. Its global footprint also creates foreign exchange exposure, geopolitical and supply-chain sensitivity, and dependence on hospital capital and procurement budgets.
- Healthcare purchasing cyclesImpact: HighLikelihood: High
Hospital budgets, tenders, and procedure volumes can shift demand and timing of purchases.
Exposure: Hospital and public sector customers
- Regulatory and clinical complianceImpact: HighLikelihood: Medium
Medical devices require approvals, quality controls, and ongoing compliance in many jurisdictions.
Exposure: Orthopaedics and surgical devices
- Foreign exchange volatilityImpact: MediumLikelihood: High
Sales and costs span many currencies, so translation and transaction effects can move reported results.
Exposure: Global operations
- Supply chain and geopolitical disruptionImpact: MediumLikelihood: Medium
A global manufacturing and distribution model is exposed to logistics, trade, and regional disruptions.
Exposure: Around 100-country footprint
Accounting
Judgemental itemsManagement uses underlying revenue growth adjusted for currency translation, which can differ from reported growth.
Impact: Affects comparability of period-to-period sales trends
Multi-currency operations create translation effects on revenue, expenses, and net assets.
Impact: Can materially change reported performance
Acquisitions and branded product portfolios require ongoing impairment assessment.
Impact: May create non-cash charges if expectations weaken
Medical device businesses may record warranty, recall, or legal provisions.
Impact: Can affect operating expense and liabilities
Similar listed companies
Publicly listed companies with a comparable business focus.
Stryker Corporation
SYK · Surgical & Medical Instruments & Apparatus
Nuo Therapeutics, Inc.
AURX · Surgical & Medical Instruments & Apparatus
ENvue Medical, Inc.
FEED · Orthopedic, Prosthetic & Surgical Appliances & Supplies
OrthoPediatrics Corp
KIDS · Surgical & Medical Instruments & Apparatus
Enovis CORP
ENOV · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Enovis is a U.S.-based medical technology company focused on orthopedic and musculoskeletal care.
Globus Medical, Inc
GMED · Surgical & Medical Instruments & Apparatus
Globus Medical is a U.S.-based medical device company focused on musculoskeletal care, with products used in spine, orthopedic trauma, hip, knee, extremity and neurosurgical procedures.
Last updated: 28/09/2026